Skip to main content
NIH funding notice PAR-20-279

Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)

Closed on August 10, 2023.

Posted
July 27, 2020
Close date
August 10, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,756,173 in first-year total cost, median $703,656.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 PXN-F (11)]3
  2. Special Emphasis Panel[ZDA1 JRB-A (J1)]2
  3. Special Emphasis Panel[ZDA1 JRB-M (J2)]1
  4. Special Emphasis Panel[ZDA1 PXN-F (17)]1

Most frequent institutions

  1. UNIVERSITY OF PITTSBURGH AT PITTSBURGH2
  2. CORIDEA, LLC1
  3. NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1
  4. RUTGERS THE STATE UNIV OF NJ NEWARK1
  5. UNIVERSITY OF COLORADO DENVER1
Competing awards under PAR-20-279 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Modulating ventral striatal activity and connectivity with transcranial focused ultrasound as a putative novel intervention for cocaine use disorder1UG3DA060431-01FERRARELLI, FABIOMOUSSAWI, KHALEDPHILLIPS, MARY LOUISEUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$700,219ZDA1
2023Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose1UG3DA058439-01COMER, SANDRA DGUEDES, ALONSOLEVIN, HOWARDWAGENER, GEBHARDCORIDEA, LLC, NY$927,319ZDA1
2023Augmenting cognitive-behavioral therapy with rTMS of the medial prefrontal and anterior cingulate cortices for the treatment of cocaine use disorder1UG3DA056138-01A1LEVIN, FRANCES RUDNICKMARTINEZ, DIANA MNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY$728,927ZDA1
2022Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder1UG3DA054746-01A1ABOSCH, AVIVASAKAI, JOSEPH TTANABE, JODY LUNIVERSITY OF COLORADO DENVER, CO$721,027ZDA1
2022Limbic Pallidum DBS for the treatment of severe alcohol use disorder1UG3AA030505-01GONZALEZ-MARTINEZ, JORGE ALVAROKRAEMER, KEVIN LMOUSSAWI, KHALEDUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$703,656ZDA1
2022Low-intensity focused ultrasound for cocaine use disorder: High resolution targeting of the human insula1UG3DA054789-01A1AIT-DAOUD, NASSIMALEGON, WYNNUNIVERSITY OF VIRGINIA, VA$602,320ZDA1
2022Recovery of reward function in nicotine use disorder using a combination of robotics, electrophysiology, and TMS1UG3DA054787-01A1BAKER, TRAVIS E.RUTGERS THE STATE UNIV OF NJ NEWARK, NJ$372,705ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-20-279: Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional) | ScienceDex | ConductScience